Cite
HARVARD Citation
Afolabi, M. et al. (2022). Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial. Lancet infectious diseases. 22 (1), pp. 110-122. [Online].